13 July 2020 - PHARMAC, on behalf of the New Zealand Government COVID-19 vaccine strategy task force, is seeking information regarding COVID-19 vaccine research, manufacture and supply, including supplier willingness to consider a range of different commercial scenarios for supply to New Zealand.

The COVID-19 vaccine strategy is based around five pillars:

• Connecting globally to contribute to all aspects of vaccine development, distribution and use
• Investing in research that contributes to global efforts, builds relationships and supports early access to a vaccine
• Developing the ability to manufacture in case it is needed to secure supply
• Optimising regulatory approaches to ensure safety, support research and enable manufacturing
• Using purchasing arrangements to secure supply where possible and to enhance resilience

Read PHARMAC Request for Proposal